Wu Tsai Neurosciences Institute


Showing 1-6 of 6 Results

  • Kari Nadeau, MD, PhD

    Kari Nadeau, MD, PhD

    Professor - University Medical Line, Medicine

    Current Research and Scholarly InterestsDr. Kari Nadeau’s laboratory and clinical research is focused on understanding the role of genes and the environment, including climate change, on the rising incidence of allergies and asthma. By understanding the genetic, epigenetic, cellular, and humoral factors that mediate immune tolerance or allergy to foods, aeroallegens, and air pollutants (e.g., diesel emissions and wildfires), her research is laying the groundwork for potential future therapies to prevent and cure allergies and asthma.

  • Claude M. Nagamine, DVM, PhD

    Claude M. Nagamine, DVM, PhD

    Associate Professor of Comparative Medicine

    Current Research and Scholarly InterestsMouse models to study murine and human infectious diseases. These colloborative studies include dengue virus, zika virus, adeno-associated virus, coxsackie virus, enterovirus 71, enterohepatic helicobacters, campylobacters, and anaplasma.

  • William Newsome

    William Newsome

    Harman Family Provostial Professor and Professor of Neurobiology and, by courtesy, of Psychology

    Current Research and Scholarly InterestsNeural processes that mediate visual perception and visually-based decision making. Influence of reward history on decision making.

  • Quan Dong Nguyen, MD, MSc

    Quan Dong Nguyen, MD, MSc

    Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)

    Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.

    We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders.

  • Anthony Norcia

    Anthony Norcia

    Professor (Research) of Psychology
    On Leave from 10/01/2022 To 03/31/2023

    Current Research and Scholarly InterestsVision, development, functional imaging, systems analysis

  • Paul Nuyujukian

    Paul Nuyujukian

    Assistant Professor of Bioengineering and of Neurosurgery and, by courtesy, of Electrical Engineering

    Current Research and Scholarly InterestsOur group explores neuroengineering and its application to both basic and clinical neuroscience. Our goal is to develop brain-machine interfaces as a platform technology for a variety of brain-related medical conditions including stroke and epilepsy.